26 September 2023
Current Oncology | Top Cited Papers in 2022 in the Section “Hematology”

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Hematology” below:

1. “Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls”
by Magda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, Andrea Palicelli, David Pellegrini, Sabrina Farinacci, Alessandra Soriano, Elisabetta Froio, Luigi Cormio, Giuseppe Carrieri et al.
Curr. Oncol. 2022, 29(2), 956–968; https://doi.org/10.3390/curroncol29020081
Available online: https://www.mdpi.com/1718-7729/29/2/81

2. “Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology”
by Evgenii Shumilov, Paolo Mazzeo, Martin S. Zinkernagel, Myriam Legros, Naomi Porret, Lorenz Romagna, Detlef Haase, Georg Lenz, Urban Novak, Yara Banz et al.
Curr. Oncol. 2022, 29(2), 766–776; https://doi.org/10.3390/curroncol29020065
Available online: https://www.mdpi.com/1718-7729/29/2/65

3. “Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients”
by Isacco Ferrarini, Francesca Gandini, Ettore Zapparoli and Antonella Rigo
Curr. Oncol. 2022, 29(4), 2792–2797; https://doi.org/10.3390/curroncol29040227
Available online: https://www.mdpi.com/1718-7729/29/4/227

4. “The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review”
by Adam Suleman, Abi Vijenthira, Alejandro Berlin, Anca Prica and Danielle Rodin
Curr. Oncol. 2022, 29(2), 892–900; https://doi.org/10.3390/curroncol29020076
Available online: https://www.mdpi.com/1718-7729/29/2/76

5. “Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging Therapies”
by Margaret E. Stalker and Tomer M. Mark
Curr. Oncol. 2022, 29(7), 4464–4477; https://doi.org/10.3390/curroncol29070355
Available online: https://www.mdpi.com/1718-7729/29/7/355

6. “Concurrent Waldenstrom’s Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation”
by Peter A. DeRosa, Kyle C. Roche, Victor E. Nava, Sunita Singh, Min-Ling Liu and Anita Agarwal
Curr. Oncol. 2022, 29(7), 4587–4592; https://doi.org/10.3390/curroncol29070363
Available online: https://www.mdpi.com/1718-7729/29/7/363

7. “Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma”
by Emilio Bellitti, Pierluigi Masciopinto, Pellegrino Musto, Elena Arcuti, Luca Mastracci, Giuseppina Opinto, Sabino Ciavarella, Attilio Guarini, Gerardo Cazzato, Giorgina Specchia et al.
Curr. Oncol. 2022, 29(9), 6115–6124; https://doi.org/10.3390/curroncol29090480
Available online: https://www.mdpi.com/1718-7729/29/9/480

8. “Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?”
by Mitchell Sabloff, Steven Tisseverasinghe, Mustafa Ege Babadagli and Rajiv Samant
Curr. Oncol. 2021, 28(1), 903–917; https://doi.org/10.3390/curroncol28010089
Available online: https://www.mdpi.com/1718-7729/28/1/89

9. “Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools”
by Beatrice Melli, Pietro Gentile, Davide Nicoli, Enrico Farnetti, Stefania Croci, Fabrizio Gozzi, Elena Bolletta, Luca De Simone, Francesca Sanguedolce, Andrea Palicelli et al.
Curr. Oncol. 2022, 29(10), 6908–6921; https://doi.org/10.3390/curroncol29100543
Available online: https://www.mdpi.com/1718-7729/29/10/543

10. “Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment”
by Matthew Ho, Alexander Xiao, Dongni Yi, Saurabh Zanwar and Giada Bianchi
Curr. Oncol. 2022, 29(11), 8975–9005; https://doi.org/10.3390/curroncol29110705
Available online: https://www.mdpi.com/1718-7729/29/11/705

Back to TopTop